相关实验视频

Updated: Jul 4, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

妊娠 trofhoblastic瘤的分子分析:确定治疗目标

Leah McNally¹, Sharon Wu², Kurt Hodges²

¹Duke University, Durham, NC, USA.

Gynecologic oncology

|February 1, 2024

概括

这项研究揭示了高PD-L1阳性在妊娠 trofhoblastic瘤 (GTN),支持免疫疗法试验. 分子分析确定了新型GTN疗法的TP53,HRR和RTK-RAS途径等潜在目标.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

高风险或复发的妊娠 trofhoblastic瘤 (GTN) 治疗涉及有毒化疗.
检查点抑制剂显示有前途,但需要针对GTN的新疗法.
了解GTN的分子特征对于确定新的治疗点至关重要.

研究的目的:

描述孕期热囊细胞瘤 (GTN) 的分子格局.
根据分子变化来确定GTN的潜在治疗点.

主要方法:

分析了30个GTN样本 (胆癌,ETT,PSTT等). 使用下一代测序 (NGS) /全外基因组测序 (WES) 和免疫组织化学 (IHC).

主要成果:

GTN样本显示高PD-L1阳性 (92.3%),低瘤突变负担 (92.8%),并且微卫星稳定 (MSS) (100%).
在46%的胆 ?? 瘤中发现了基因组变异,包括TP53 (33%) 和同源重组修复 (HRR) 基因 (13%).
RTK-RAS通路的改变存在于40%的上皮状热质瘤 (ETT).

结论:

高PD-L1阳性支持GTN免疫疗法的进一步临床试验.
确定了潜在的向治疗方法:针对TP53,HRR和RTK-RAS变化的Wee1,PARP和MEK抑制剂.

关键词:

胆 ?? 瘤是一种胆 ?? 瘤.在ETT ETT上.怀孕期的 trofhoblastic 新生病.分子造型分析 (MOP) 是一种分子造型分析.在PD-L1中.这是PSTTTT.

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues

Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues

Published on: October 20, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...